Serum prolactin and the suppression of lactation
- PMID: 788774
- DOI: 10.1111/j.1471-0528.1976.tb00912.x
Serum prolactin and the suppression of lactation
Abstract
Bromocriptine (2 bromo-alpha-ergocryptine), stilboestrol, clomiphene citrate, testosterone propionate and a placebo were given to 75 postpartum women for the suppression of puerperal lactation. An additional 15 women who breast-fed their babies served as a control group. Blood samples were taken for the determination of serum prolactin levels by a specific homologous double antibody radioimmunoassay. Concurrently, the clinical effectiveness of the various treatments was assessed. High levels of prolactin were found at the time of delivery. Bromocriptine effectively reduced serum prolactin and prevented lactation; stilboestrol increased serum prolactin and partially suppressed lactation; clomiphene citrate and testosterone propionate both lowered serum prolactin levels and partially suppressed lactation. The placebo showed almost no effect on serum prolactin. It appeared that bromocriptine was the drug of choice in the suppression of puerperal lactation.
Similar articles
-
Inhibition of puerperal lactation by bromocriptine.Acta Endocrinol Suppl (Copenh). 1978;216:119-30. Acta Endocrinol Suppl (Copenh). 1978. PMID: 347857 Clinical Trial.
-
[The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].Geburtshilfe Frauenheilkd. 1977 Jun;37(6):500-8. Geburtshilfe Frauenheilkd. 1977. PMID: 328335 Clinical Trial. German.
-
A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].Br J Clin Pharmacol. 1975 Aug;2(4):368P-369P. doi: 10.1111/j.1365-2125.1975.tb02790.x. Br J Clin Pharmacol. 1975. PMID: 788734 Clinical Trial. No abstract available.
-
Lactation suppression.Clin Obstet Gynecol. 1980 Dec;23(4):1045-59. doi: 10.1097/00003081-198012000-00008. Clin Obstet Gynecol. 1980. PMID: 7004693 Review.
-
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.Drugs. 1995 Feb;49(2):255-79. doi: 10.2165/00003495-199549020-00009. Drugs. 1995. PMID: 7729332 Review.
Cited by
-
Treatments for suppression of lactation.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005937. doi: 10.1002/14651858.CD005937.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972088 Free PMC article.
-
Therapeutic applications of bromocriptine in endocrine and neurological diseases.Drugs. 1988 Jul;36(1):67-82. doi: 10.2165/00003495-198836010-00005. Drugs. 1988. PMID: 3063495 Review.
-
Optic neuritis during lactation.Graefes Arch Clin Exp Ophthalmol. 1985;222(3):134-8. doi: 10.1007/BF02173537. Graefes Arch Clin Exp Ophthalmol. 1985. PMID: 3979833
-
Use of bromocriptine in the inhibition of puerperal lactation.Drugs. 1979 May;17(5):326-36. doi: 10.2165/00003495-197917050-00002. Drugs. 1979. PMID: 378648 Review. No abstract available.
-
Suppressing lactation.Br Med J. 1977 Jan 22;1(6055):189. Br Med J. 1977. PMID: 832068 Free PMC article. No abstract available.